exome sequencing Jul 11, 2022 Immune Checkpoint Blockade Response Linked to Recurrent Mutations in Genes, Pathways Jun 15, 2022 Pan-Cancer Analyses Reveal Copy Number Signatures, Chromosomal Instability Patterns Jun 2, 2022 Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership Apr 11, 2022 Cancer Genomics Project in Southwestern American Indians Aims to Improve Research, Care Disparities Apr 10, 2022 Phylogenetic Analysis IDs Subset of De Novo Tumors Unrelated to Primary DCISÂ Premium Apr 7, 2022 Pangea Biomed Builds on RNA-Based Drug Matching to Expand Precision Oncology Opportunities Premium Mar 29, 2022 Zentalis Pharmaceuticals, Caris Life Sciences Ink Precision Oncology Partnership Mar 25, 2022 Initial KidsCanSeq Findings Reveal Medical Recommendations Stemming From Germline Tests Mar 2, 2022 Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases Feb 18, 2022 Invitae Launches Study to Generate Real-World Data on Personalized MRD Test Across Tumor Types Premium Feb 9, 2022 Large-Scale Cancer Genome Analysis Reveals Mutation Clusters That Can Inform Prognosis Nov 17, 2021 Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups Oct 13, 2021 Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration Oct 8, 2021 TGen Study Highlights Value of Repeat Tumor Profiling for Pediatric Solid Tumors Premium Aug 11, 2021 Sema4, Avera Health Collaborate on Precision Oncology Program Jul 9, 2021 Integrated Tumor, Microbiome Features Influence Immunotherapy Combo Effects in Advanced Melanoma Jul 1, 2021 Higher Early-Onset Cancer Risk Among Minorities Spurs Hunt for Genetic, Environmental Factors Premium Jun 4, 2021 Breast Cancer Genomics Study Reveals Recurrent Contributors to Treatment Resistance in Early Disease May 20, 2021 Quantgene Attempts to Woo Consumers With Liquid Biopsy Cancer Risk Assessment Service Premium May 17, 2021 Oncologists, Patients Still Face Unpredictable Payor Coverage for Broad Tissue NGS Panels Premium Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
